Skip to content

The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns

The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00156988
Enrollment
Unknown
Registered
2005-09-12
Start date
2004-03-31
Completion date
2005-12-31
Last updated
2009-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Keywords

burns, partial thickness, cerium flamazine, randomised clinical trial

Brief summary

The objective of the proposed study is to assess whether the application of flammacerium for 2 days is as good as, or even better than, the application of flammacerium for 10 days regarding woundhealing in partial thickness burns.

Detailed description

Cerium is suggested to halt the cytokine cascade ensuing burn injury by binding the 'burn toxin' and, when used in combination with silver-sulfadiazine, may enhance its antibacterial effect. Since 1984, the combination of cerium and silver sulfadiazine, flammacerium, has been used in our centre. Current practice is to treat acute, non-facial, burns with daily cleaning and (re-)application of flammacerium for a total of ten days. However, prolonged application of cerium is thought to be unnecessary - it is effective in the early stages after injury- and prolonged application of silver sulfadiazine has a negative effect on wound healing. The objective of the proposed study is therefore, to assess whether the application of flammacerium for 2 days is as good as, or even better than, the application of flammacerium for 10 days regarding woundhealing in partial thickness burns.

Interventions

DRUGcerium nitrate-silver sulfadiazine (cerium-flamazine)

Sponsors

Dutch Burns Foundation
CollaboratorOTHER
Association of Dutch Burn Centres
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients having partial thickness burns with TBSA of \< 10%

Exclusion criteria

* patients not seen within 24 hours postburn * patients with only facial burns * patients with electrical or chemical burns * patients or their parents/caregivers with mental or cognitive deficits that may interfere with providing informed consent

Design outcomes

Primary

MeasureTime frame
number of days required for wound healing, judged clinically and assessed as both number of days till 95% and 100% re-epithelialisation by planimetry at the time the decision regarding surgery is made (8-10 pb) and as wounds are considered healed

Secondary

MeasureTime frame
Wound colonisation, assessed by swabs taken at 0 or 3 days pb, 7 days pb and subsequently every 7 days until wounds are healed or treated surgically, and on indication

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026